N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect-Reference-Cited by-同舟云学术

N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

Published:2023-10 Issue: Volume:258 Page:115570
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Espejo-Román Jose M.,Rubio-Ruiz Belén,Chayah-Ghaddab Meriem,Vega-Gutierrez Carlos,García-García Gracia,Muguruza-Montero Arantza,Domene Carmen,Sánchez-Martín Rosario M.,Cruz-López Olga,Conejo-García Ana^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Sung;A Cancer J. Clin.,2021

2. Hyaluronan: a modulator of the tumor microenvironment;Chanmee;Cancer Lett.,2016

3. Hyaluronan-CD44 interactions as potential targets for cancer therapy: targeting CD44 variants in tumors;Misra;FEBS J.,2011

4. Hyaluronan-CD44 axis orchestrates cancer stem cell functions;Skandalis;Cell. Signal.,2019

5. Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides;Slomiany;Clin. Cancer Res.,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxytyrosyl punicate: A first overview of a novel phenolipid with antiproliferative and antitrypanosomal activity;Journal of Functional Foods;2024-06

2. CD44 and its implication in neoplastic diseases;MedComm;2024-05-23